Innotox 50unit Reconstitution and Handling: A Professional Reference

Innotox 50unit, manufactured by Medytox in South Korea, is presented as a liquid botulinum toxin type A solution. Unlike traditional lyophilized powders, its liquid formulation offers distinct characteristics for storage and preparation. This product is intended strictly for professional use within aesthetic practices, requiring trained personnel to manage its storage, reconstitution, and application protocols.

Clinics seeking a reliable supply of neurotoxins will find Innotox 50unit a consistent option within the broader category of botulinum toxin products. Understanding its unique properties is essential for effective inventory management and clinic operations.

Maintaining the integrity of Innotox 50unit begins with stringent cold chain management upon receipt and continues through its storage life. Prior to reconstitution, vials should be stored refrigerated at 2°C to 8°C (36°F to 46°F). Freezing the product is not recommended and can compromise its efficacy.

• Upon Arrival: Verify cold chain indicators and inspect packaging for any signs of damage or temperature excursions. Document lot numbers and expiration dates for inventory tracking.
• Storage Environment: Keep vials in their original packaging, protected from light. Ensure refrigeration units are consistently monitored for temperature accuracy. Secure storage helps prevent accidental freezing or exposure to excessive heat, which can degrade the active compound. Similar cold chain protocols apply to other liquid toxins like certain presentations of Nabota 100unit.

The reconstitution process for Innotox 50unit involves careful dilution with a sterile, preservative-free normal saline (0.9% sodium chloride) solution. Always adhere to aseptic techniques throughout this process to prevent contamination.

1. Preparation: Gather all necessary sterile equipment: syringes, needles, diluent vials, and antiseptic wipes. Clean the rubber stopper of the Innotox vial with an alcohol swab.
2. Diluent Withdrawal: Using a sterile syringe, withdraw the desired volume of 0.9% sterile saline. The specific volume depends on the target concentration for your clinic’s use.
3. Diluent Injection: Slowly inject the saline into the Innotox 50unit vial. It is crucial to avoid injecting the diluent directly onto the product, as this can cause frothing and denaturation. Instead, direct the saline gently down the inner wall of the vial.
4. Mixing: Do not shake the vial. Gently swirl the vial to ensure complete and uniform mixing. Shaking can denature the botulinum toxin. The reconstituted solution should be clear and colorless, free of particulate matter. For comparison, products like Re N Tox 100unit also emphasize gentle mixing techniques during their preparation.

The final concentration of Innotox 50unit after reconstitution is determined by the volume of diluent added. Clinic protocols often specify concentrations based on their operational needs. The following table provides common dilution ratios for reference:

These guidelines help clinics standardize their preparation procedures. It is critical to clearly label reconstituted vials with the date, time of reconstitution, and concentration to ensure accurate use and adherence to post-reconstitution storage limits. When stocking multiple neurotoxin presentations, such as Coretox 200 units, consistent labeling practices are vital.

Once reconstituted, Innotox 50unit must be stored under refrigeration at 2°C to 8°C (36°F to 46°F). The stability of the reconstituted solution is typically maintained for a specific duration, generally within 24 hours. Always consult the specific product insert provided by Medytox for precise post-reconstitution storage recommendations and shelf-life.

Protect the reconstituted solution from light. Any unused portion after the recommended period should be discarded according to local regulatory guidelines for biohazardous waste. This strict adherence minimizes potential degradation and supports professional practice standards.

Before any preparation, a thorough inspection of the Innotox 50unit packaging and vials is a mandatory step. Examine the outer carton for any signs of damage, tampering, or moisture exposure. The presence of intact seals and valid expiration dates are key indicators of product integrity.

Upon opening, visually inspect the glass vial for cracks or damage. The rubber stopper should be firm and securely seated. The product within the vial, prior to reconstitution, should appear as a clear, colorless liquid. Any discoloration, cloudiness, or particulate matter suggests potential compromise, and such vials should not be used.

Efficient wholesale sourcing of aesthetic injectables like Innotox 50unit is crucial for clinic profitability and uninterrupted service. Establishing relationships with reputable distributors ensures access to authentic products with verified cold chain adherence. When stocking Innotox 50unit, consider its unit price of $67.8, with volume-tiered discounts starting at 11 units (4% off) and increasing to 8% off for orders of 51 units or more.

Effective inventory management involves tracking expiration dates, monitoring usage rates, and optimizing order quantities to minimize waste and capitalize on wholesale pricing tiers. This strategic approach ensures your clinic maintains an adequate supply of essential neurotoxins while managing costs effectively.